AVALUN
Created in 2013
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,686Activities
Entity types
Location
7 Parv. Louis Néel, 38000 Grenoble, France
Grenoble
France
Employees
Scale: 11-50
Estimated: 19
SIREN
799055520Engaged corporates
4
4 0Added in Motherbase
1 year, 7 months ago
healthtech Value proposition
Connected Biology Everywhere.
While AVALUN's technology has enabled us to design a portable mini-lab that you can hold in your hands, our aim is, above all, to leave you free to invent the care pathways that go with it.
New care pathways freed from the constraints of place and time, so that you can use every minute saved to take better care of others, or take better care of your health. The ultra-compact design of our LabPad range focuses on portability and accessibility. Since the daily life of each patient should be the place where everything happens, the LabPad has been designed to adapt to all terrains. The terrain of laboratories that wish to go outside their walls to meet patients. The field of practitioners who want to gain efficiency by performing tests in their office as well as wherever it is useful to make the right decision without delay. The field of nurses concerned with facilitating the daily life of their patients, whether in their office, at home or in nursing homes. Finally, the patients themselves, who wish to be fully involved in their own health.
With a constantly evolving range of tests available for the same reader, LabPad technology is establishing its status as the best friend of healthcare professionals and patients. A mobile, complete, all-in-one laboratory is now available to reinvent patient pathways.
With AVALUN, connected biology is now available everywhere.
in vitro diagnostics, point of care testing, connected health, patient selftesting, Covid-19 tests, and INR testOriginal language
Connected Biology Everywhere.
While AVALUN's technology has enabled us to design a portable mini-lab that you can hold in your hands, our aim is, above all, to leave you free to invent the care pathways that go with it.
New care pathways freed from the constraints of place and time, so that you can use every minute saved to take better care of others, or take better care of your health. The ultra-compact design of our LabPad range focuses on portability and accessibility. Since the daily life of each patient should be the place where everything happens, the LabPad has been designed to adapt to all terrains. The terrain of laboratories that wish to go outside their walls to meet patients. The field of practitioners who want to gain efficiency by performing tests in their office as well as wherever it is useful to make the right decision without delay. The field of nurses concerned with facilitating the daily life of their patients, whether in their office, at home or in nursing homes. Finally, the patients themselves, who wish to be fully involved in their own health.
With a constantly evolving range of tests available for the same reader, LabPad technology is establishing its status as the best friend of healthcare professionals and patients. A mobile, complete, all-in-one laboratory is now available to reinvent patient pathways.
With AVALUN, connected biology is now available everywhere.
AVALUN – Connected Biology Everywhere
https://avalun.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Grenoble Alpes National and local authorities, Public Relations and Communications Services | Grenoble Alpes National and local authorities, Public Relations and Communications Services | Other 29 Jan 2025 | | |
 PMT Public business cluster, French Cluster, Civic and Social Organizations | PMT Public business cluster, French Cluster, Civic and Social Organizations | Other 2 Apr 2024 | | |
 MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 31 Jul 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 17 Apr 2024 | | |